ThermoGenesis - THMO Real Price to Acquire Entire Company

Symbol and logo of brand Cesca Therapeutics (THMO)

ThermoGenesis is developing partnerships with biobanks to automate stem cell workflows, confirming the market trend on GURU.Markets, which stands at . The business's success relies on the advancement of cell therapy and compliance with GMP standards. The sale of components ensures a steady cash flow, although research limits are constraining a sharp price increase for the installations themselves.

THMO Cesca Therapeutics: Enterprise Value in the range 07/04/2022 - 10/27/2026

ThermoGenesis (THMO) - metric breakdowns and financial figures

- price and consensus price forecast:
Price Performance Chart ThermoGenesis Holdings, Inc.|THMO - Price Target Chart
- market capitalization data:
Market Valuation ThermoGenesis|THMO - Total Company Value
- book capitalization data:
Net Asset Value per Share ThermoGenesis|THMO - Book Capitalization|Capitalization to Book Value Ratio thermogenesis.com|THMO - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Coefficient ThermoGenesis|THMO - Long-Term Debt to Capital|Short-Term Debt to Capital thermogenesis.com|THMO - Company Aggregate Debts|Debt to Net Assets ThermoGenesis
Summary company analysis:ThermoGenesis Holdings, Inc. (THMO)
Original product of ThermoGenesis

Enterprise Value (EV) represents the total cost of acquiring a business, combining market capitalization and net debt to determine the actual cost for a buyer. By analyzing the dynamics of the total enterprise value, an investor can see how debt load and liquidity impact the valuation of ThermoGenesis (THMO), whose capitalization is supported by a steady cash flow from the mandatory sale of consumables for installed blood processing systems.

Competitor analysis

Abbott Labs - Value Adjusted for Debt and Cash|TMO: Total Company Value|GEHC: Real Price to Acquire Entire Company|Total Company Value MTD|waters.com (WAT) - Total Enterprise Value|Enterprise Value Bio-Techne (TECH)|Business Value Bruker Corp|AZTA (Azenta Life Sciences) - Enterprise Value|Company Buyout Price Varex Imaging Corp. (VREX)|Enterprise Value SMLR (Semler Scientific, Inc.)|Enterprise Value butterflynetwork.com BFLY|Enterprise Value MLAB|QSI: Full Takeover Company Value|Total Company Value Nanox|QTRX (Quanterix Inc) - Business Value|Total Company Value MASS (908 Devices Inc.)|Total Enterprise Value CV|MXCT (MaxCyte) - Total Company Value|Company Buyout Price rapidmicrobio.com RPID|Real Price to Acquire Entire Company Seer Inc. (SEER)|Aggregate Business Value Hyperfine Medical HYPR|Enterprise Value FONR (FONAR Corporation)|DXR - Company Buyout Price|MDAI (Spectral AI) - Enterprise Value|Real Price to Acquire Entire Company VivoSim Labs|ACON - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash AKYA|Total Company Value TLIS (Talis Biomedical)|Real Price to Acquire Entire Company t2biosystems.com (TTOO)